All Stories

  1. Patient recall bias of reactions affects safety of outpatient drug challenges

    Article • Annals of Allergy Asthma & Immunology, January 2026, Elsevier

    Dr Sujoy Khan

  2. Comment on: NETs in the spotlight: exploring NETosis markers for tracking disease activity in IgA vasculitis

    Article • Rheumatology, July 2025, Oxford University Press (OUP)

    Dr Sujoy Khan

  3. Concerns Regarding Use of High-Dose Cyclosporine in the Management of Refractory Chronic Spontaneous Urticaria

    Article • Indian Dermatology Online Journal, April 2025, Wolters Kluwer Health

    Dr Sujoy Khan

  4. Abstracts

    Article • British Journal of Haematology, April 2025, Wiley

    Dr Sujoy Khan

  5. Role of Thymic Dysfunction in the Pathogenesis of Lichen Planus

    Article • Indian Dermatology Online Journal, October 2024, Wolters Kluwer Health

    Dr Sujoy Khan

  6. British Society for Allergy and Immunology Abstracts From the 2024 Annual Conference

    Article • Clinical & Experimental Allergy, October 2024, Wiley

    Dr Sujoy Khan

  7. Comment on: Evaluation of the ACR/EULAR 2022 criteria for classification of ANCA-associated vasculitis in a population-based cohort from Sweden

    Article • Rheumatology, July 2024, Oxford University Press (OUP)

    Dr Sujoy Khan

  8. Comment on: van der Rijst LP et al

    Article • July 2024, Authorea, Inc.

    Dr Sujoy Khan

  9. Comment on: van der Rijst LP et al.

    Article • Pediatric Allergy and Immunology, July 2024, Wiley

    Dr Sujoy Khan

  10. Tumid lupus erythematosus in C1-inhibitor deficiency

    Article • The Journal of the Royal College of Physicians of Edinburgh, May 2024, SAGE Publications

    Dr Sujoy Khan

  11. Comment on Tuten Dal S et al

    Article • April 2024, Authorea, Inc.

    Dr Sujoy Khan

  12. Comment on Tuten Dal S et al

    Article • Pediatric Allergy and Immunology, March 2024, Wiley

    Dr Sujoy Khan

  13. Deciding noninferiority margins for non–intramuscular adrenaline delivery systems

    Article • Annals of Allergy Asthma & Immunology, March 2024, Elsevier

    Dr Sujoy Khan

  14. Route and dosage of intramuscular-alternative epinephrine delivery systems remains undetermined

    Article • Annals of Allergy Asthma & Immunology, March 2024, Elsevier

    Dr Sujoy Khan

  15. Whole blood immune memory cells is not sufficient to predict SARS-CoV-2 vaccine responsiveness

    Article • Indian Journal of Medical Microbiology, November 2023, Elsevier

    Dr Sujoy Khan

  16. British Society for Allergy and Immunology (BSACI) Abstracts of the 2023 UK Conference (5–7 October, Harrogate Convention Centre, Harrogate, UK)

    Article • Clinical & Experimental Allergy, September 2023, Wiley

    Dr Sujoy Khan

  17. Immunomodulation mediated by polyclonal IgG replacement in patients with chronic lymphocytic leukemia may be important in infection prevention

    Article • Hematological Oncology, May 2022, Wiley

    Dr Sujoy Khan

  18. Resistant Chronic Spontaneous Urticaria – A Case Series Narrative Review of Treatment Options

    Article • Allergy & Rhinology, January 2022, SAGE Publications

    Dr Sujoy Khan

  19. Interstitial lung disease in common variable immunodeficiency

    Article • British Journal of Hospital Medicine, December 2021, Mark Allen Group

    Dr Sujoy Khan

  20. BSACI Registry for Immunotherapy (BRIT): Providing safe and effective immunotherapy for allergies and urticaria

    Article • Clinical & Experimental Allergy, August 2021, Wiley

    Dr Sujoy Khan

  21. Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal?

    Article • Rheumatology, April 2021, Oxford University Press (OUP)

    Dr Sujoy Khan

  22. Ibrutinib does not reverse disease- and treatment-related hypogammaglobulinaemia associated with chronic lymphocytic leukemia

    Article • Leukemia & Lymphoma, February 2021, Taylor & Francis

    Dr Sujoy Khan

  23. Evaluating sensitization patterns on ImmunoCAP-detected polysensitized patients with microarray-based multiplex assay (ISAC)

    Article • Journal of Allergy and Clinical Immunology, February 2021, Elsevier

    Dr Sujoy Khan

  24. Using National Registries to Identify Targeted Therapies for Refractory Urticaria

    Article • International Archives of Allergy and Immunology, January 2021, Karger Publishers

    Dr Sujoy Khan

  25. Epigenetic alterations on C1-inhibitor expression may influence hereditary angioedema attack frequency and C4 levels

    Article • Clinical & Experimental Immunology, October 2020, Oxford University Press (OUP)

    Dr Sujoy Khan

  26. Emerging and Reemerging Sexually Transmitted Infections

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2020, New England Journal of Medicine (NEJM/MMS)

    Dr Sujoy Khan

  27. Mast cell tryptase level should be checked in all patients with suspected Kounis syndrome

    Article • European Heart Journal, July 2020, Oxford University Press (OUP)

    Dr Sujoy Khan

  28. Anti-phospholipid syndrome and valvular pathology

    Article • Journal of Echocardiography, July 2020, Springer Science + Business Media

    Dr Sujoy Khan

  29. Omalizumab retreatment rates in chronic spontaneous urticaria

    Article • European Annals of Allergy and Clinical Immunology, May 2020, Edra SpA

    Dr Sujoy Khan

  30. Comment on: Vaginal dryness in primary Sjögren’s syndrome: a histopathological case–control study

    Article • Rheumatology, April 2020, Oxford University Press (OUP)

    Dr Sujoy Khan

  31. Understanding the cholesterol and cytokine network in patients with adrenal insufficiency and cirrhosis

    Article • The Journal of the Royal College of Physicians of Edinburgh, March 2020, Royal College of Physicians of Edinburgh

    Dr Sujoy Khan

  32. Chlorhexidine in swabs - friend or foe?

    Article • British Journal of Nursing, February 2020, Mark Allen Group

    Sujoy Khan, Dr Sujoy Khan

  33. Do ribosomal protein alterations affect ER stress response in CVID?

    Article • Clinical & Experimental Immunology, February 2020, Oxford University Press (OUP)

    Dr Sujoy Khan

  34. Comment on Bertrand et al

    Article • Pediatric Allergy and Immunology, January 2020, Wiley

    Dr Sujoy Khan

  35. JAK Inhibition with Methotrexate as Treatment for COVID-19 Is a Double-Edged Sword

    Article • International Archives of Allergy and Immunology, January 2020, Karger Publishers

    Dr Sujoy Khan

  36. Role of translational controlled tumor protein in omalizumab resistance

    Article • Allergy and Asthma Proceedings, January 2020, Oceanside Publications Inc.

    Dr Sujoy Khan

  37. Urticaria in patients with diabetes: Adverse drug reaction or relapse of underlying autoimmune urticaria?

    Article • International Journal of Microbiology Research, January 2019, Scientific Scholar

    Dr Sujoy Khan

  38. Testing for Fecal Calprotectin in Food Protein–Induced Enterocolitis Syndrome

    Article • Journal of Investigational Allergology and Clinical Immunology, August 2018, Esmon Publicidad, SA

    Dr Sujoy Khan

  39. Aspergillus fumigatus IgG level greater than 60 mg/L Increases Diagnostic Specificity of Allergic Bronchopulmonary Aspergillosis

    Article • Journal of Allergy and Clinical Immunology, February 2018, Elsevier

    Dr Sujoy Khan

  40. Indolent systemic mastocytosis manifesting as protracted anaphylactic shock

    Article • Indian Journal of Critical Care Medicine, January 2018, Jaypee Brothers Medical Publishing

    Dr Sujoy Khan

  41. Chronic Urticarial Vasculitis and Immunoglobulin-G Monoclonal Gammopathy: Variant Schnitzler Syndrome

    Article • EMJ Dermatology, November 2017, European Medical Group

    Dr Sujoy Khan

  42. Celiac Disease in Children – A Profile from a Predominantly Rice Eating Population

    Article • Journal of Clinical Gastroenterology and Hepatology, January 2017, Scitechnol Biosoft Pvt. Ltd.

    Dr Sujoy Khan

  43. Evidence of Parthenium sensitivity across all seasons in patients from middle and lower gangetic regions

    Article • Indian Journal of Dermatology, January 2016, Medknow

    Dr Sujoy Khan

  44. Chronic granulomatous disease may be an underlying cause for invasive nocardiosis

    Article • Lung India, January 2016, Medknow

    Dr Sujoy Khan

  45. Letter in response to previous publication in IJD® Drug-induced CD30+skin lesions: Complex interplay between infectious agents, human leukocyte antigen system and mast cells/T cells

    Article • Indian Journal of Dermatology, January 2016, Medknow

    Dr Sujoy Khan

  46. Does immunoglobulin therapy have a role in treating Dengue virus infection with induced systemic capillary leak syndrome?

    Article • Journal of Pediatric Intensive Care, July 2015, IOS Press

    Dr Sujoy Khan

  47. Low calculated globulin to identify unsuspected antibody deficiency

    Article • Annals of Clinical Biochemistry International Journal of Laboratory Medicine, May 2015, SAGE Publications

    Professor Stephen Holding, Dr Sujoy Khan

  48. Antiphospholipid syndrome is an important modifiable risk factor of stroke in the young

    Article • Annals of Indian Academy of Neurology, January 2015, Medknow

    Dr Sujoy Khan

  49. Persistent cow′s milk allergy with attacks of anaphylaxis

    Article • Indian Journal of Allergy Asthma and Immunology, January 2015, Medknow

    Dr Sujoy Khan

  50. Helicobacter Pylori Associated Urticarias

    Article • Allergology International, January 2014, Japanese Society of Allergology

    Dr Sujoy Khan

  51. Raised immunoglobulin E levels are not predictive of allergic reactions to blood products

    Article • Asian Journal of Transfusion Science, January 2014, Medknow

    Dr Sujoy Khan

  52. The Pitfalls of FeNO Testing

    Article • Allergology International, January 2013, Japanese Society of Allergology

    Dr Sujoy Khan

  53. Ocular manifestations of the antineutrophil cytoplasmic antibody and antiphospholipid syndromes

    Article • Indian Journal of Ophthalmology, January 2013, Medknow

    Dr Sujoy Khan

  54. Comparison of Cytokine Responses with Anti-D and Intravenous Immunoglobulin in Idiopathic Thrombocytopenia

    Article • Transfusion Medicine and Hemotherapy, January 2013, Karger Publishers

    Dr Sujoy Khan

  55. More robust evidence and safety checks are required before autologous serum therapy as treatment for chronic urticaria can be recommended

    Article • Indian Journal of Dermatology, January 2013, Medknow

    Dr Sujoy Khan

  56. Chronic Urticaria: Indian Context—Challenges and Treatment Options

    Article • Dermatology Research and Practice, January 2013, Hindawi Publishing Corporation

    Dr Sujoy Khan

  57. Allergic diseases of the skin and drug allergies – 2021. Efficacy of montelukast as add-on therapy in patients with chronic idiopathic urticaria

    Article • World Allergy Organization Journal, January 2013, Elsevier

    Dr Sujoy Khan

  58. Efficacy of Montelukast as Added Therapy in Patients with Chronic Idiopathic Urticaria

    Article • Inflammation & Allergy - Drug Targets, April 2012, Bentham Science Publishers

    Dr Sujoy Khan

  59. Reply

    Article • Pediatric Allergy and Immunology, March 2012, Wiley

    Dr Sujoy Khan

  60. Reply

    Article • Pediatric Allergy and Immunology, March 2012, Wiley

    Dr Sujoy Khan

  61. The Finding of Anticardiolipin Autoantibodies in Patients With Pseudoexfoliation Syndrome Requires Further Evaluation

    Article • Journal of Glaucoma, March 2012, Wolters Kluwer Health

    Dr Sujoy Khan

  62. Abnormal IL‐7 signaling may lead to the loss of bone mineral density in common variable immunodeficiency

    Article • Pediatric Allergy and Immunology, March 2012, Wiley

    Dr Sujoy Khan

  63. Chronic urticaria and use of statins

    Article • Asia Pacific Allergy, January 2012, Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI)

    Dr Sujoy Khan

  64. Should we be giving enhanced vitamin D intakes to all?

    Article • The Journal of the Royal College of Physicians of Edinburgh, January 2012, SAGE Publications

    Dr Sujoy Khan

  65. The role of hypoxia-inducible factor-1 alpha in TEMPI syndrome

    Article • Clinical Kidney Journal, October 2011, Oxford University Press (OUP)

    Dr Sujoy Khan

  66. PLA2 receptor autoantibodies, complement activation and podocyte damage

    Article • Nephrology Dialysis Transplantation, September 2011, Oxford University Press (OUP)

    Dr Sujoy Khan

  67. Letters to the editor

    Article • The Journal of the Royal College of Physicians of Edinburgh, June 2011, SAGE Publications

    Dr Sujoy Khan

  68. Expanding indications of omalizumab therapy in the absence of specific IgE

    Article • Allergologia et Immunopathologia, May 2011, Codon Publications

    Dr Sujoy Khan

  69. Serum Trough IgG level and Annual Intravenous Immunoglobulin Dose Are Not Related to Body Size in Patients on Regular Replacement Therapy

    Article • Drug Metabolism Letters, April 2011, Bentham Science Publishers

    Dr Sujoy Khan

  70. Regulatory T-Cell Detection by Flow Cytometry and Systemic Sclerosis

    Article • Clinical and Translational Science, February 2011, Wiley

    Dr Sujoy Khan

  71. Administering intravenous immunoglobulin during infection is associated with infusion reactions in selected patients

    Article • Irish Journal of Medical Science (1971 -), December 2010, Springer Science + Business Media

    Dr Sujoy Khan

  72. Do ribosomopathies explain some cases of common variable immunodeficiency?

    Article • Clinical & Experimental Immunology, November 2010, Oxford University Press (OUP)

    Dr Sujoy Khan

  73. Anti-acetylcholine receptor antibody reactivity of IgG in commercial immunoglobulin preparations

    Article • Clinical Neurology and Neurosurgery, November 2010, Elsevier

    Dr Sujoy Khan

  74. Recurrent infections with Aspergillus require exclusion of defects in the phagocyte NADPH oxidase pathway

    Article • Indian Journal of Medical Microbiology, July 2010, Elsevier

    Dr Sujoy Khan

  75. Anti-IL-5 therapy and DRESS

    Article • Canadian Medical Association Journal, June 2010, Canadian Medical Association (CMA)

    Dr Sujoy Khan

  76. Systemic Capillary Leak Syndrome Should be Considered in the Differential Diagnosis of Multi-Organ Failure and Hypovolemic Shock

    Article • The Pediatric Infectious Disease Journal, June 2010, Wolters Kluwer Health

    Dr Sujoy Khan

  77. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome

    Article • Journal of Allergy and Clinical Immunology, February 2010, Elsevier

    Dr Sujoy Khan

  78. Pitfalls in the Diagnosis of Latex Allergy

    Article • Allergology International, January 2010, Japanese Society of Allergology

    Dr Sujoy Khan

  79. The Epithelial Mucin (MUC1) and Virus-Specific Antibodies Target Cell-Free Human Immunodeficiency Virus in Human Breast Milk

    Article • The Pediatric Infectious Disease Journal, October 2009, Wolters Kluwer Health

    Dr Sujoy Khan

  80. Warfarin can be safe and effective in the extreme elderly

    Article • Age and Ageing, September 2009, Oxford University Press (OUP)

    Dr Sujoy Khan

  81. Reply

    Article • Age and Ageing, September 2009, Oxford University Press (OUP)

    Dr Sujoy Khan

  82. Pharmacotherapy for gastric antral vascular ectasia: dramatic response to tranexamic acid

    Article • Gastrointestinal Endoscopy, July 2009, Elsevier

    Dr Sujoy Khan

  83. Lichen planus in a case of Good's syndrome (thymoma and immunodeficiency)

    Article • Interactive Cardiovascular and Thoracic Surgery, May 2009, Oxford University Press (OUP)

    Dr Sujoy Khan

  84. Limited value of testing for intrinsic factor antibodies with negative gastric parietal cell antibodies in pernicious anaemia: Figure 1

    Article • Journal of Clinical Pathology, April 2009, BMJ

    Dr Sujoy Khan

  85. Intravenous immunoglobulin-induced neutropenia

    Article • Pediatric Allergy and Immunology, April 2009, Wiley

    Dr Sujoy Khan

  86. A Patient Survey on the Use and Effectiveness of Aerosolized Epinephrine (Primatene mist inhaler) for Treatment of Anaphylaxis/angioedema

    Article • Journal of Allergy and Clinical Immunology, February 2009, Elsevier

    Dr Sujoy Khan

  87. Comparison of Commercial Nonammoniated and Ammoniated Latex Skin Prick Testing Solutions by SDS-PAGE

    Article • Journal of Allergy and Clinical Immunology, February 2009, Elsevier

    Dr Sujoy Khan

  88. Invasive cryptococcus infections in immunocompetent individuals may suggest defects in CD40/CD40L signaling pathway

    Article • Indian Journal of Pathology and Microbiology, January 2009, Medknow

    Dr Sujoy Khan

  89. Both autoantibodies and pathogen-specific antibodies are present in immunoglobulin preparations and reflect characteristics of the donor population

    Article • Journal of the American Academy of Dermatology, December 2008, Elsevier

    Dr Sujoy Khan

  90. The value of total IgE levels in the context of specific allergy

    Article • Pediatric Allergy and Immunology, November 2008, Wiley

    Dr Sujoy Khan

  91. Cardiac complications may be higher with use of proteasome inhibitors in patients with rheumatoid arthritis

    Article • Medical Hypotheses, November 2008, Elsevier

    Dr Sujoy Khan

  92. Hypoxia and Alzheimer disease

    Article • Canadian Medical Association Journal, June 2008, Canadian Medical Association (CMA)

    Dr Sujoy Khan

  93. The clinical significance of antinucleolar antibodies

    Article • Journal of Clinical Pathology, February 2008, BMJ

    Dr Sujoy Khan

  94. Both patient characteristics and IVIG product‐specific mechanisms may affect eosinophils in immunoglobulin‐treated Kawasaki disease

    Article • Pediatric Allergy and Immunology, February 2008, Wiley

    Dr Sujoy Khan

  95. Some cases of common variable immunodeficiency may be due to a mutation in the SBDS gene of Shwachman–Diamond syndrome

    Article • Clinical & Experimental Immunology, January 2008, Oxford University Press (OUP)

    Dr Sujoy Khan

  96. Abnormal O-glycosylation of CD43 may account for some features of Wiskott-Aldrich syndrome

    Article • Medical Hypotheses, January 2008, Elsevier

    Dr Sujoy Khan

  97. Nimesulide and adverse drug reactions

    Article • Journal of Postgraduate Medicine, January 2008, Medknow

    Dr Sujoy Khan

  98. Risks of Intravenous Immunoglobulin in Sepsis Affect Trial Design

    Article • Annals of Internal Medicine, December 2007, American College of Physicians

    Dr Sujoy Khan

  99. Could oral spleen tyrosine kinase inhibitors lead to neoplastic transformation?

    Article • Journal of Allergy and Clinical Immunology, May 2007, Elsevier

    Dr Sujoy Khan

  100. Secondary systemic lupus erythematosus: An analysis of 4 cases of uncontrolled hereditary angioedema

    Article • Clinical Immunology, April 2007, Elsevier

    Dr Sujoy Khan

  101. Metronidazole-Induced Aseptic Meningitis during Helicobacter pylori Eradication Therapy

    Article • Annals of Internal Medicine, March 2007, American College of Physicians

    Dr Sujoy Khan

  102. The Clinical Significance Of Isolated Antinucleolar Antibodies

    Article • Journal of Allergy and Clinical Immunology, January 2007, Elsevier

    Dr Sujoy Khan

  103. Clinical utility of the Coombs test

    Article • Canadian Medical Association Journal, October 2006, Canadian Medical Association (CMA)

    Dr Sujoy Khan

  104. CORRECTION

    Article • Postgraduate Medical Journal, August 2006, Oxford University Press (OUP)

    Dr Sujoy Khan

  105. Hepatitis C: reviewing the options

    Article • Canadian Medical Association Journal, July 2006, Canadian Medical Association (CMA)

    Dr Sujoy Khan

  106. Oral immunosuppressive drugs

    Article • Clinical Medicine, July 2006, Elsevier

    Dr Sujoy Khan

  107. Early indicators of immunodeficiency in adults and children: protocols for screening for primary immunological defects

    Article • Clinical & Experimental Immunology, June 2006, Oxford University Press (OUP)

    Dr Sujoy Khan

  108. Musculoskeletal and myotoxic side-effects in a patient treated for psoriasis

    Article • British Journal of Dermatology, May 2006, Oxford University Press (OUP)

    Dr Sujoy Khan

  109. Use of amino terminal type III procollagen peptide (P3NP) assay in methotrexate therapy for psoriasis

    Article • Postgraduate Medical Journal, May 2006, Oxford University Press (OUP)

    Dr Sujoy Khan

  110. Conjugate vaccines and polysaccharide response

    Article • Canadian Medical Association Journal, March 2006, Canadian Medical Association (CMA)

    Dr Sujoy Khan

  111. Biopeptides and immune exclusion

    Article • Canadian Medical Association Journal, January 2006, Canadian Medical Association (CMA)

    Dr Sujoy Khan

  112. Persistence of Natural Killer (NK) cell lymphocytosis with hyposplenism without development of leukaemia

    Article • BMC Clinical Pathology, September 2005, Springer Science + Business Media

    Dr Sujoy Khan

  113. Psoriasis

    Article • The New England Journal of Medicine and Surgery and the Collateral Branches of Science, August 2005, New England Journal of Medicine (NEJM/MMS)

    Dr Sujoy Khan